Weight Loss Plateaus and the Brain's Gray Areas The National Institutes of Health has made a significant breakthrough in understanding how GLP 1 weight loss medications like Ozempic and Wegovy interact with brain cells.
Research published in Nature Metabolism reveals that semaglutide sparks distinct responses within appetite controlling neurons, offering a possible explanation for the varying effectiveness of these medications.
The study's findings are consistent with the complexities of human metabolism and the intricate mechanisms of the brain.